Cardiovascular Ultrasound Market (By Type: Transthoracic Echocardiography, Transoesophageal Echocardiography, Foetal Echocardiography, Others; By Technology: 2D, 3D/4D, Doppler, Others; By Display: Black & White (B/W), Color; By End-use: Hospital, Diagnostic Centers, Ambulatory Care Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

The global cardiovascular ultrasound market size was estimated at USD 2.65 billion in 2023 and is expected to hit around USD 4.67 billion by 2032 and is poised to grow at a CAGR of 6.5% over the forecast period 2023 to 2032. The U.S. cardiovascular ultrasound market was valued at USD 517.9 million in 2022.

Cardiovascular Ultrasound Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • North America led the global market with the highest market share of 31% in 2022.
  • Asia Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
  • By Type, the transthoracic echocardiography segment has held the largest market share in 2022.
  • By Technology, the doppler segment captured the biggest revenue share in 2022.
  • By Display, the black and white (B/W) segment is estimated to hold the highest market share of 89% in 2022.

Cardiovascular Ultrasound Market in the U.S. 2023 To 2032

The U.S. cardiovascular ultrasound market size was valued at USD 549.49 million in 2023 and is expected to reach USD 976.71 million by 2032, growing at a CAGR of 6.60% from 2023 to 2032.

U.S. Cardiovascular Ultrasound Market Size 2023 to 2032

North America held the biggest income portion of over 31% in 2022 attributable to the better framework in medical care offices and the high reception of CVUS in preventive medication.

In the U.S., the installments for Medicare are settled on different elements including relative worth units, transformation factors, and geographic practice cost records. The Medicare accompanies new guidelines, which choose the repayment strategy. The steady repayment strategy and administrative structure are supposed to assist with impelling the market development around here over the conjecture period.

North America is expected to lead the market attributable to the high reception of ultrasound methodology overall diagnostics and the rising predominance of way of life related ongoing infections. The popularity for mechanically progressed clinical gadgets is supposed to impel market development in the area.

As per the American Heart Association Research Report 2018, Heart sickness represents 1 of every 7 passings in the United States. Coronary Heart Disease is the main source (43.8%) of passings owing to cardiovascular sickness in the United States, trailed by stroke (16.8%), cardiovascular breakdown (9.0%), hypertension (9.4%), illnesses of the veins (3.1%), and other cardiovascular illnesses (17.9%). This situation prompts a more popularity for cardiovascular ultrasound frameworks for better determination, which will drive the market in the United States.

Besides, strong mindfulness drives for sickness mindfulness are projected to help the market for cardiovascular gadgets in North America. For example, in 2020, Mexico joined the HEARTS drive to reinforce essential medical services for CVD. Advanced by the Pan American Health Organization/World Health Organization (PAHO/WHO), the drive plans to work on the anticipation and control of hypertension at the essential consideration level.

Notwithstanding, Asia Pacific is supposed to be the quickest developing provincial market at a CAGR of over 7% over the estimated period. This development can be credited to the rising commonness of ongoing circumstances in the district.

Cardiovascular Ultrasound Market Share, By Region, 2022 (%)

Regions Revenue Share in 2022 (%)
North America 31%
Asia Pacific 22%
Europe 27%
Latin America 13%
MEA 7%


Growth Factors

The central point for the development of the cardiovascular ultrasound framework market incorporates - the rising occurrence of cardiovascular sicknesses (CVDs), ascend in mechanical headways, and benefits of echocardiography over obtrusive heart analytic strategies.

Cardiovascular sicknesses (CVD) stay a significant reason for dismalness and mortality in the created world and are turning into an undeniably significant reason for death in non-industrial nations. According to the 2020 updates of the World Health Organization, ischemic coronary illness, liable for 16% of the world's complete passings. Starting around 2000, the biggest expansion in passings has been for ischemic coronary illness, ascending by multiple million to 8.9 million passings in 2019. Subsequently, the expansion in the quantity of cardiovascular illnesses has expanded the interest for the cardiovascular ultrasound framework for finding.

Mechanical headway, for example, man-made reasoning emphatically affects cardiology with further developed capacities to analyze specific heart conditions. For example, in October 2020, GE Healthcare got the US FDA 510k freedom for its ultra version bundle of distinctive cardiovascular ultrasound frameworks, which incorporates new highlights in view of man-made reasoning (AI) that empower clinicians to procure quicker, more repeatable tests reliably.

An ascent in entrance of preventive medication and expanding predominance of cardiovascular diseases (CVDs) are supposed to drive the market development. The COVID-19 pandemic hampered the worldwide market development as short-term imaging administrations were unfavorably impacted. Cardiovascular sicknesses, for example, coronary illness, respiratory failure, and stroke, are among the significant reasons for death in the U.S. Changing way of life has expanded inclination to CVDs. For example, as per the CDC, in 2017, 28.2 million grown-ups were determined to have coronary illness in the U.S. ultrasound innovation is utilized to actually take a look at irregularities in the working of the heart, for example, siphoning limit of the heart, working of valves, and plaque in the heart.

These gadgets go about as significant symptomatic gear that can help in diminishing the frequency of cardiovascular failure and stroke by giving an early determination. Accordingly, the developing predominance of heart issues is expected to drive the market over the gauge period. Cardiovascular ultrasound (CVUS) played a significant device to survey cardiovascular capabilities in the COVID-19 patients since any circumstances connected with the heart framework expanded the gamble of mortality.

Cardiovascular harm post-COVID-19 recuperation is one of the central point expected to drive the market development. As indicated by a worldwide concentrate by New York's Mount Sinai Hospital, 66% of the COVID-19 recuperated patients were seen to have a heart primary irregularity. Cardiovascular ultrasound is broadly utilized in surveying these patients. This is supposed to help the interest for new and high level CVUS frameworks during the figure time frame. There are different repayment strategies connected with ultrasound, internationally. The U.S. involved HOPPS pay strategy to finish up on repayment strategy for various kinds of heart ultrasounds.

The extension for heart ultrasound methods depends on conditions and conditions specified under a singular's protection plan, as there are different kinds of techniques like electrocardiography, transthoracic echocardiography, and 3D echocardiography. Protection associations have different rules that are utilized to set repayment rates. They can deny protection in view of inclining factors. On occasion, protection refusal might be in light of the fact that a trained professional and protection organization have changing treatment rationalities.

Cardiovascular Ultrasound  Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 6.5%
Market Size in 2023 USD 2.65 Billion
Market Size by 2032 USD 4.67 Billion
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Type, Technology, Display, End-use, Geography
Regions Covered

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Type Insights

Based on type, the worldwide market has been fragmented into transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, and others. The transthoracic echocardiography segment represented over 55% of the general income share in 2022. Then again, the fetal echocardiography section is supposed to witness the quickest CAGR of 7.5% during the estimate time frame.

A fetal echocardiogram is one of the pregnancy tests, which is acted in the second trimester to check whether each of the four offices of the heart are created in the hatchling. It permits picturing the construction of the unborn youngster's heart. Expanding levels of mindfulness about hatchling wellbeing are driving the development of this portion.

Technology Insights

In view of innovation, the market is divided into 2D, 3D/4D, and Doppler ultrasound frameworks. Doppler is the most favored framework as they give sharp pictures in a more limited time and the fragment represented the greatest income portion of more than 47% in 2022. The strategy is acquiring unmistakable quality in agricultural nations, like India and China, attributable to the rising entrance of mechanically progressed frameworks in these nations.

Doppler echocardiography assists measure with blooding stream inside the heart without utilizing any obtrusive techniques. What's more, studios directed for Doppler echocardiography are supposed to support its reception. For example, in March 2019, Radcliffe Cardiology directed a studio on 2D and Doppler echocardiography in Vail. It covered points, like the utilization of the Doppler strategy for hemodynamics and cardiovascular capability and its application in hemodynamics, remembering for valvular coronary illness. In this way, progressions in Doppler innovation to upgrade heart imaging are supposed to support the general section development.

The COVID-19 affected the development of 2D cardiovascular ultrasound frameworks in 2020. Moreover, the deferral of elective methodology because of COVID-19-related gauges antagonistically impacted the cardiovascular clinical gadgets market, particularly in the year 2020. While a few cardiovascular systems are thought of as critical, others have been deferred and postponed starting from the start of the worldwide pandemic. Subsequently, way of life changes and medicine can be briefly endorsed rather than cardiovascular techniques for certain patients. Another element adversely affecting the verticle is the decrease in the analysis of cardiovascular illnesses because of medical services assets being held for COVID-19 patients.

2D ultrasound imaging is otherwise called B-mode echography or sonography. It shows a 2D guide of B-mode information and is as of now the most widely recognized type of heart ultrasound imaging utilized around the world. It utilizes numerous transducers. It empowers the age of numerous pictures of the field or approaches consistently on the screen, giving a deception of development. It is essentially used to gauge heart chamber aspects, survey valvular construction and capability, and work on the exactness of translation of Doppler modalities.

2D ultrasound is one of the most well-known types of innovation utilized. Notwithstanding, it has weaknesses, similar to low goal, contortion of ultrasound wave bringing about wrong pictures, perspective on the inward bone design, and local situation.

Additionally, innovative headways, similar to Doppler imaging and 3D/4D ultrasound imaging, are supposed to influence the worldwide 2D imaging market during the conjecture time frame. For example, in October 2020, Royal Philips sent off the Ultrasound 3300, another imaginative ultrasound series custom-made for general Imaging and cardiovascular imaging methods. Such item progression will help vertical development throughout the next few years.

Display Insights

Based in display view, the market is sectioned into black and white (B/W) and variety ultrasound frameworks. The variety frameworks section represented the most noteworthy income portion of over 89% in 2022. This is on the grounds that variety frameworks are generally liked over B/W because of the lucidity of pictures presented by these frameworks. Also, variety cardiovascular ultrasound helps in better conclusion. Hitachi has a progression of variety frameworks, which are accessible across the globe.

Cardiovascular Ultrasound Market Share, By Display, 2022 (%)

Because of this multitude of elements, the variety frameworks fragment is additionally expected to enlist the quickest CAGR of around 7.4% over the gauge period. B/W frameworks can be utilized with 2D, 3D/4D, and Doppler ultrasound gadgets. Many driving organizations, like Siemens Healthcare and Philips Healthcare, have B/W gadgets. These gadgets are utilized in wellbeing communities with financial plan limitations to move to the variety mode.

End Users Insights

Based on end use, the market is sectioned into clinics, wandering consideration communities, analytic focuses, and others. The clinics fragment represented the biggest income portion of over 43% in 2022. Clinical imaging goes about as a significant wellspring of short-term benefit, hence different mid-to-huge estimated clinics introduce clinical imaging gear inside their premises.

Most of enormous scope clinics have their own clinical imaging offices. Notwithstanding, clinical imaging offices are high-support and require weighty ventures, enormous space, and gifted experts. These elements increment the monetary weight on clinics in overseeing such offices. Subsequently, clinics incline toward collaborating with symptomatic habitats for clinical imaging offices. This aides in cost-saving, particularly in little and moderate sized medical clinics.

Key Market Developments

  • In October 2020, GE Healthcare got the FDA leeway for Vivid Ultra Edition, an AI-controlled intended to abbreviate symptomatic test time and further develop estimation consistency.
  • In August 2020, Philips sent off its new Affiniti CVx and 7.0 for EPIQ CVx cardiovascular ultrasound arrangements, which incorporate upgrades to improve trust in determination and systems and further develop the client experience.
  • In October 2020, Royal Philips sent off Ultrasound 3300 in India. The item can be utilized for a large number of utilizations including OB/GYN, cardiovascular imaging, and general imaging.
  • In 2015, GE Healthcare marked a notice of understanding with the Oregon Health and Science University (U.S.) to embrace cooperative R&D concentrates on in the field of cardiovascular imaging and treatment as well as in large information research
  • In 2015, GE Healthcare sent off another 4D heart ultrasound programming — cSound — for three new ultrasound frameworks, to be specific, VividS70, VividE90, and VividE95 in the U.S. what's more, a few nations in Europe, Asia, and Latin America.

The key market players are constantly engaged in various developmental strategies like partnership, collaborations, new product launches, and acquisitions to strengthen their market position and gain market share.

Cardiovascular Ultrasound Market Companies

  • GE Healthcare
  • Koninklijke Philips
  • Siemens Healthineers AG
  • Hitachi Medical Corp.
  • Samsung Medison Co. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)
  • Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
  • Fujifilm Sonosite, Inc.

Segments Covered in the Report

By Type

  • Transthoracic Echocardiography
  • Transoesophageal Echocardiography
  • Foetal Echocardiography
  • Others

By Technology 

  • 2D
  • 3D/4D
  • Doppler
  • Others

By Display 

  • Black & White (B/W)
  • Color

By End-use

  • Hospital
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the current size of cardiovascular ultrasound market?
The global cardiovascular ultrasound market size was accounted at USD 2.65 billion in 2023 and it is expected to reach around USD 4.67 billion by 2032.
What will be the CAGR of global cardiovascular ultrasound market?
The global cardiovascular ultrasound market is poised to grow at a CAGR of 6.5% from 2023 to 2032.
Who are the prominent players operating in the cardiovascular ultrasound market?
The major players operating in the cardiovascular ultrasound market are GE Healthcare, Koninklijke Philips, Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray), Chison Wuxi Xiangsheng Medical Technology Co., Ltd., Fujifilm Sonosite, Inc.
Which are the driving factors of the cardiovascular ultrasound market?
The main considerations for the development of the cardiovascular ultrasound framework market incorporate - the rising rate of cardiovascular sicknesses (CVDs), ascend in mechanical headways, and benefits of echocardiography over obtrusive heart demonstrative methodology.
Which region will lead the global cardiovascular ultrasound market?
North America region will lead the global cardiovascular ultrasound market during the forecast period 2023 to 2032.


   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500


No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample